Is the Negative Prognostic Value of High Oestrogen Receptor (ER) Levels in Postmenopausal Breast Cancer Patients Due to a Modified ER Gene Product?

Author: Sancho-Garnier H.   Delarue J.-C.   Mouriesse H.   Contesso G.   May-Levin F.   Gotteland M.   May E.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.31, Iss.11, 1995-10, pp. : 1851-1855

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content